Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by HippygirL74on Feb 04, 2008 1:39am
385 Views
Post# 14312500

RE: klaatutu- are you there?

RE: klaatutu- are you there?klaatutu, wow, thanks for your reply.  Because i expect very little from IR, i was hoping that you might share your insight or educated guess as to the specific nature of these animal studies.  i now understand what is meant by "clean", but what do you think is the "clear-cut, unequivocal evidence" that the FDA is looking for.  If anyone here can answer that question, it would have to be you- just an opinion or an educated guess from you would be great.

The company does not have to announce specifics about the animal studies.  All they have to say with each quarterly announcement is that they plan to submit on time in early 2009.  From this, i can extrapolate that all is well.  

And if all is well, the price will slowly creep upwards.    

As for those analyst that are "quiet", well, there isn't that much to talk about at this time.  You know as well as i do, that the price can be engineered to the upside or downside.  When it is time to raise money, then there will be something to talk about, so until then, there is nothing to say.

As "horla" stated about Labopharm (DDS-TSX), just look at how a few positive words can affect the shareprice- it is off 100% from the lows now.  The same will happen with Nuvo. 

klaatutu, once again, thank you very much for your time.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse